Casopitant (GW679769) oral tablets

DRUG3 trials

Sponsors

GlaxoSmithKline

Conditions

NauseaNausea and Vomiting, Chemotherapy-InducedVomiting

Phase 1

A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers

CompletedNCT00404274

GlaxoSmithKlineNausea and Vomiting, Chemotherapy-Induced

Start: 2006-11-01End: 2007-03-18Updated: 2017-08-09

A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults

CompletedNCT00437229

GlaxoSmithKlineNausea and Vomiting, Chemotherapy-Induced

Start: 2007-02-19End: 2007-05-15Updated: 2017-11-13

Phase 3

Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting

CompletedNCT00366834

GlaxoSmithKlineNausea, Nausea and Vomiting, Chemotherapy-Induced, Vomiting

Start: 2006-07-31End: 2009-10-31Updated: 2012-09-10